Precious Metals Investing

Business

Uber's Autonomous Ambitions Face Reality Check as New Jersey Ruling Reclassifies Drivers

Uber Technologies is aggressively expanding its autonomous vehicle ecosystem through new partnerships and its AV Labs division, even as a landmark New Jersey court decision threatens to upend its core gig-economy labor model, setting the stage for a pivotal clash between its future vision and present-day regulatory challenges.

Jan 30, 2026

Business

Elevra Lithium's Sharp Sell-Off Sparks Valuation Debate: Correction or Opportunity?

Elevra Lithium (ASX:ELV) shares have tumbled over 30% in a week, abruptly reversing a stellar year-long rally. With no clear catalyst, investors are left weighing whether the pullback presents a buying window or signals deeper concerns in the lithium sector.

Jan 30, 2026

Business

Summit Therapeutics: A Tale of Two Valuations Amidst Steep Share Price Decline

Summit Therapeutics (SMMT) finds itself at a crossroads, with its stock down over 30% in the past year. Conflicting signals from valuation models paint a complex picture: is the biotech firm dramatically overvalued on traditional metrics, or deeply undervalued based on future cash flows?

Jan 30, 2026

Business

Northeast Bank's Loan Surge and New SMB Product Spark Investor Debate Amid Rising Charge-Offs

Northeast Bank's Q2 2026 results reveal a bank in transition: record loan growth and a promising new small business product are countered by rising charge-offs and a token dividend, leaving analysts divided on its investment narrative.

Jan 30, 2026

Business

Canada Grants Conditional Lifeline for Marineland's Stranded Belugas, Paving Way for U.S. Transfer

Federal officials have issued provisional approval to relocate 30 beluga whales and four dolphins from the shuttered Ontario park to accredited U.S. aquariums, averting an immediate euthanasia threat pending final health and care plans.

Jan 30, 2026

World

Newcastle's Castle Leazes Secures £274m Revamp, Doubling Student Capacity

A major redevelopment of Newcastle University's Castle Leazes student village is moving forward, with contractor Bowmer + Kirkland appointed to deliver over 2,000 new affordable rooms, replacing 1960s-era facilities.

Jan 30, 2026

Business

Peloton's Path to Profitability: All Eyes on Cost Control as Earnings Loom

As Peloton Interactive prepares to report its Q2 fiscal 2026 results, investors are scrutinizing whether the fitness company's aggressive cost-cutting can finally fuel a sustainable turnaround, despite shares languishing 96% below their peak.

Jan 30, 2026

Business

MarineMax Navigates Choppy Waters: Premium Sales Buoy Q4 Revenue as Margins Face Squeeze

MarineMax's Q4 2025 results surpassed revenue forecasts, driven by robust premium boat sales, but profitability was hampered by industry-wide discounting and cautious consumer spending, leading to a wider-than-expected loss per share.

Jan 30, 2026

Business

Intuitive Machines Bolsters Space Ambitions with $800M Lanteris Acquisition and NASA Artemis II Role

Intuitive Machines (LUNR) is set to acquire Lanteris Space Systems in an $800 million deal, expanding its capabilities into vertically integrated space infrastructure. Concurrently, NASA has selected the company to provide critical tracking support for the upcoming Artemis II crewed lunar mission, signaling growing trust in its technical prowess.

Jan 30, 2026

Business

El Salvador Doubles Down on Gold, Acquires $50 Million in Bullion Amid Global Rush

The Central American nation makes its second major gold purchase in months, fortifying reserves as it balances pioneering Bitcoin bets with traditional safe-haven assets during a period of market volatility.

Jan 30, 2026

Business

Beyond Nvidia: Two AI Infrastructure Giants Poised for Growth as Tech Titans Ramp Up Spending

With hyperscalers projected to pour $500 billion into AI infrastructure by 2026, investors are looking beyond headline chipmakers to the essential, yet often overlooked, backbone providers of the AI revolution.

Jan 30, 2026

Business

AI Infrastructure Showdown: Can IREN and APLD Sustain Their Meteoric Rise?

Once crypto miners, IREN and Applied Digital have pivoted to AI infrastructure, delivering staggering returns. But as valuations soar, investors face a critical choice between predictable cash flow and high-growth optionality.

Jan 30, 2026

Business

Coca-Cola's Enduring Appeal: Why the Beverage Giant Remains a Cornerstone Investment

Amidst market volatility, Coca-Cola (KO) stands out with its formidable brand moat and a 63-year dividend growth streak, offering investors a blend of stability and reliable income.

Jan 30, 2026

Business

Krones AG Shares Surge: Strong Financials Fuel Investor Confidence

Krones AG (ETR:KRN) has seen its stock price climb 11% in the past quarter. Analysis points to robust fundamentals, particularly a healthy Return on Equity (ROE) of 14%, as a key driver behind the market's bullish sentiment and the company's impressive earnings growth trajectory.

Jan 30, 2026

Business

Stryker Caps Strong 2025 with Record Robotics Growth, Eyes Further Expansion Amid Tariff Headwinds

The medical technology giant reported double-digit organic sales growth and robust profitability for 2025, driven by record installations of its Mako surgical robots. While projecting continued strength for 2026, management acknowledged incremental tariff pressures but expressed confidence in the company's ability to sustain margin expansion.

Jan 30, 2026

Business

Sherwin-Williams Navigates 'Softer for Longer' Market to Post Strong Q4, Eyes Modest 2026 Growth

Despite a persistently muted demand environment, Sherwin-Williams reported robust fourth-quarter earnings, driven by cost discipline and strategic acquisitions. The paint giant forecasts low-to-mid single-digit sales growth for 2026 while reinstating employee benefits, signaling cautious optimism amid ongoing economic headwinds.

Jan 30, 2026

Business

Genmab Shares Face Target Cut After EPKINLY Trial Misses Survival Goal, But Analysts Keep Faith

H.C. Wainwright has trimmed its price target on Genmab following mixed Phase 3 results for its lymphoma drug EPKINLY, though maintains a Buy rating, citing precedent and ongoing trials.

Jan 30, 2026

Business

AUTO1 Group's Three-Year Surge: Shareholders Still Up 239% Despite Recent Dip

Despite a recent 6.8% pullback, AUTO1 Group SE (ETR:AG1) has delivered a staggering 239% return to its shareholders over the past three years, highlighting the potential rewards of holding through market volatility. We examine the underlying business trends and investor sentiment behind the numbers.

Jan 30, 2026

Business

Bargain Hunt: UK Stocks Trading at Steep Discounts Amid Market Jitters

As the FTSE indices reel from weak Chinese trade data, a screen of undervalued UK equities reveals potential opportunities. We examine three companies trading significantly below their estimated cash flow value.

Jan 30, 2026

Business

PennyMac Mortgage Investment Trust Posts Strong Q4 on Securitization Surge, Navigates Production Headwinds

PennyMac Mortgage Investment Trust (PMT) closed 2025 with robust earnings, driven by a dramatic expansion in its private-label securitization business. While this growth fueled returns, the company's correspondent lending segment faced pressure, and faster mortgage prepayments impacted servicing rights income.

Jan 30, 2026